Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Nomura, Kyoichi"" wg kryterium: Autor


Wyświetlanie 1-20 z 20
Tytuł:
Churg-Strauss syndrome manifesting as perforation of the small intestine: report of a case.
Autorzy:
Murakami S; Department of Surgery, Saitama Medical School, Morohonngo 38, Moroyama-machi, Saitama 350-0945, Japan.
Misumi M
Sakata H
Hirayama R
Kubojima Y
Nomura K
Ban S
Pokaż więcej
Źródło:
Surgery today [Surg Today] 2004; Vol. 34 (9), pp. 788-92.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Churg-Strauss Syndrome/*complications
Intestinal Perforation/*etiology
Intestinal Perforation/*surgery
Intestine, Small/*pathology
Intestine, Small/*surgery
Abdominal Pain/etiology ; Adrenal Cortex Hormones/therapeutic use ; Churg-Strauss Syndrome/drug therapy ; Female ; Humans ; Intestinal Perforation/complications ; Middle Aged ; Peritonitis/etiology ; Risk Factors
Czasopismo naukowe
Tytuł:
Distal lipid storage myopathy due to PNPLA2 mutation.
Autorzy:
Ohkuma A; Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8502, Japan.
Nonaka I
Malicdan MC
Noguchi S
Ohji S
Nomura K
Sugie H
Hayashi YK
Nishino I
Pokaż więcej
Źródło:
Neuromuscular disorders : NMD [Neuromuscul Disord] 2008 Aug; Vol. 18 (8), pp. 671-4. Date of Electronic Publication: 2008 Jul 26.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Distal Myopathies/*genetics
Lipase/*genetics
Adult ; Atrophy ; Cardiomyopathy, Dilated/etiology ; Cardiomyopathy, Dilated/genetics ; Cardiomyopathy, Dilated/pathology ; Distal Myopathies/pathology ; Hand/pathology ; Humans ; Leg/pathology ; Lipid Metabolism/genetics ; Lipid Metabolism/physiology ; Male ; Mountaineering ; Muscle Fibers, Skeletal/pathology ; Muscle Weakness/etiology ; Muscle, Skeletal/pathology ; Mutation/genetics ; Mutation/physiology
Czasopismo naukowe
Tytuł:
Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
Autorzy:
Niino M; Department of Clinical Research, Hokkaido Medical Center, Yamanote 5jo 7chome, Nishi-ku, Sapporo 063-0005, Japan. .
Mifune N
Kohriyama T
Mori M
Ohashi T
Kawachi I
Shimizu Y
Fukaura H
Nakashima I
Kusunoki S
Miyamoto K
Yoshida K
Kanda T
Nomura K
Yamamura T
Yoshii F
Kira J
Nakane S
Yokoyama K
Matsui M
Miyazaki Y
Kikuchi S
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2014 Jan 06; Vol. 14, pp. 3. Date of Electronic Publication: 2014 Jan 06.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Apathy*
Cognition Disorders/*psychology
Depression/*psychology
Fatigue/*psychology
Multiple Sclerosis/*psychology
Adolescent ; Adult ; Aged ; Cognition Disorders/diagnosis ; Cognition Disorders/epidemiology ; Depression/diagnosis ; Depression/epidemiology ; Fatigue/diagnosis ; Fatigue/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis/epidemiology ; Neuropsychological Tests ; Young Adult
Czasopismo naukowe
Tytuł:
Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders.
Autorzy:
Watanabe M; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
Kondo T; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan; Department of Community Network and Collaborative Medicine, Kyoto University Hospital, 54 Kawaharacho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. Electronic address: .
Murakata K; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
Kageyama T; Department of Neurology, Tenri Hospital, 200 Mishimacho, Tenri, Nara 632-8552, Japan. Electronic address: .
Shibata Y; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
Takahashi T; Department of Neurology, Tohoku University School of Medicine, 1-1 Seiryomachi, Aoba-ku, Sendai, Miyagi 980-8574, Japan. Electronic address: .
Nomura K; Department of Neurology, Saitama Medical Center, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Matsumoto S; Department of Neurology, Kitano Hospital Medical Research Institute, 2-4-20 Ohgimachi, Kita-ku, Osaka 530-8480, Japan. Electronic address: .
Pokaż więcej
Źródło:
Journal of neuroimmunology [J Neuroimmunol] 2014 Sep 15; Vol. 274 (1-2), pp. 155-60. Date of Electronic Publication: 2014 Jun 27.
Typ publikacji:
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Asians*
Aquaporin 4/*immunology
Autoantigens/*immunology
Membrane Proteins/*immunology
Multiple Sclerosis/*immunology
Nerve Tissue Proteins/*immunology
Neuromyelitis Optica/*immunology
Adult ; Aged ; Autoantibodies/immunology ; Encephalitis/ethnology ; Encephalitis/immunology ; Female ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/ethnology ; Neuromyelitis Optica/ethnology ; Receptors, N-Methyl-D-Aspartate/immunology
Czasopismo naukowe
Tytuł:
The 36(th) Annual Meeting of the Japanese Society for Apheresis.
Autorzy:
Nomura K; Department of Neurology, Saitama Medical Center, Saitama, Japan. .
Pokaż więcej
Źródło:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2016 Aug; Vol. 20 (4), pp. 337-8.
Typ publikacji:
Editorial
MeSH Terms:
Blood Component Removal*
Societies, Medical*
Humans ; Japan
Opinia redakcyjna
Tytuł:
Open Label Trial of the Efficacy and Safety Profile of Rikkunshito used for the Treatment of Gastrointestinal Symptoms in Patients with Parkinson's Disease: A Pilot Study.
Autorzy:
Yakabi K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Yamaguchi N; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Ono S; Department of Gastroenterology, National Hospital Organization Disaster Medical Center, Tokyo, Japan.
Yoshida N; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Hosomi E; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Hayashi K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Ochiai M; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Maezawa K; Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło:
Current therapeutic research, clinical and experimental [Curr Ther Res Clin Exp] 2017 Jul 31; Vol. 87, pp. 1-8. Date of Electronic Publication: 2017 Jul 31 (Print Publication: 2017).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Immunoadsorption in neurological disorders.
Autorzy:
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Pokaż więcej
Źródło:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2017 Oct; Vol. 56 (5), pp. 671-676. Date of Electronic Publication: 2017 Aug 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunosorbent Techniques*
Autoantibodies/*blood
Nervous System Diseases/*therapy
Humans ; Nervous System Diseases/immunology ; Plasma Exchange
Czasopismo naukowe
Tytuł:
A clinical predictive score for postoperative myasthenic crisis.
Autorzy:
Kanai T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Sato Y; Department of Global Clinical Research, Graduate School of Medicine, Chiba University, Chiba.
Suzuki S; Department of Neurology, Keio University School of Medicine, Tokyo.
Kawaguchi N; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Himuro K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Oda F; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Ozawa Y; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Nakahara J; Department of Neurology, Keio University School of Medicine, Tokyo.
Suzuki N; Department of Neurology, Keio University School of Medicine, Tokyo.
Takahashi YK; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
Ishibashi S; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
Yokota T; Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo.
Ogawa T; Department of Neurology, Juntendo University School of Medicine, Tokyo.
Yokoyama K; Department of Neurology, Juntendo University School of Medicine, Tokyo.
Hattori N; Department of Neurology, Juntendo University School of Medicine, Tokyo.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama.
Kaneko J; Department of Neurology, Kitasato University School of Medicine, Kanagawa.
Nishiyama K; Department of Neurology, Kitasato University School of Medicine, Kanagawa.
Yoshino I; Department of General Thoracic Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba.
Pokaż więcej
Źródło:
Annals of neurology [Ann Neurol] 2017 Nov; Vol. 82 (5), pp. 841-849. Date of Electronic Publication: 2017 Nov 10.
Typ publikacji:
Journal Article; Multicenter Study; Validation Study
MeSH Terms:
Myasthenia Gravis/*diagnosis
Postoperative Complications/*diagnosis
Female ; Humans ; Male ; Middle Aged ; Myasthenia Gravis/surgery ; Retrospective Studies ; Risk Factors ; Thymectomy/adverse effects
Czasopismo naukowe
Tytuł:
Markers for Guillain-Barré syndrome with poor prognosis: a multi-center study.
Autorzy:
Yamagishi Y; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Suzuki H; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Sonoo M; Department of Neurology, Teikyo University School of Medicine, Tokyo, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yokota T; Department of Neurology, Tokyo Medical and Dental University, Faculty of Medicine, Tokyo, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Faculty of Medicine, Kawagoe, Japan.
Chiba A; Department of Neurology, Kyorin University, Faculty of Medicine, Mitaka, Japan.
Kaji R; Department of Neurology, Tokushima University, Faculty of Medicine, Tokushima, Japan.
Kanda T; Department of Neurology, Yamaguchi University, Faculty of Medicine, Ube, Japan.
Kaida K; Department of Neurology, National Defense Medical College, Tokorozawa, Japan.
Ikeda SI; Department of Neurology, Shinshu University, Faculty of Medicine, Matsumoto, Japan.
Mutoh T; Department of Neurology, Fujita Health University School of Medicine, Faculty of Medicine, Toyoake, Japan.
Yamasaki R; Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takashima H; Department of Neurology, Kagoshima University, Faculty of Medicine, Kagoshima, Japan.
Matsui M; Department of Neurology, Kanazawa Medical University, Kahoku, Japan.
Nishiyama K; Department of Neurology, Kitazato University, Faculty of Medicine, Sagamihara, Japan.
Sobue G; Department of Neurology, Nagoya University, Graduate School of Medicine, Nagoya, Japan.
Kusunoki S; Department of Neurology, Kindai University, Faculty of Medicine, Osaka-sayama, Japan.
Pokaż więcej
Źródło:
Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2017 Dec; Vol. 22 (4), pp. 433-439. Date of Electronic Publication: 2017 Sep 11.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Mobility Limitation*
Outcome Assessment, Health Care*
Respiration, Artificial*
Severity of Illness Index*
Guillain-Barre Syndrome/*diagnosis
Immunoglobulin G/*blood
Adult ; Female ; Follow-Up Studies ; Guillain-Barre Syndrome/blood ; Guillain-Barre Syndrome/physiopathology ; Guillain-Barre Syndrome/therapy ; Humans ; Japan ; Male ; Middle Aged ; Patient Admission ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Mean Platelet Volume Is Associated with Early Neurological Deterioration in Patients with Branch Atheromatous Disease: Involvement of Platelet Activation.
Autorzy:
Oji S; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan. Electronic address: .
Tomohisa D; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Hara W; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Tajima T; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Suzuki M; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Saito A; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Yoshida N; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Nomura K; Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan.
Pokaż więcej
Źródło:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2018 Jun; Vol. 27 (6), pp. 1624-1631. Date of Electronic Publication: 2018 Feb 07.
Typ publikacji:
Journal Article
MeSH Terms:
Mean Platelet Volume*
Platelet Activation*
Brain Ischemia/*blood
Stroke/*blood
Adult ; Aged ; Aged, 80 and over ; Area Under Curve ; Brain Ischemia/diagnosis ; Brain Ischemia/physiopathology ; Brain Ischemia/therapy ; Disability Evaluation ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; ROC Curve ; Retrospective Studies ; Risk Factors ; Stroke/diagnosis ; Stroke/physiopathology ; Stroke/therapy ; Time Factors
Czasopismo naukowe
Tytuł:
Intravascular large B-cell lymphoma involving large blood vessels, three autopsy cases.
Autorzy:
Sato S; Department of Hematology, Shonan Kamakura General Hospital, Kamakura, Japan.; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
Teshima S; Department of Pathology, Shonan Kamakura General Hospital, Kamakura, Japan.
Nakamura N; Department of Pathology, Tokai University, School of Medicine, Isehara, Japan.
Ohtake T; Department of Nephrology, Immunology, and Vascular Medicine, Shonan Kamakura General Hospital, Kamakura, Japan.
Kikuchi J; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kishi H; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.; Department of Pathology, Doai Memorial Hospital, Tokyo, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Kurose N; Department of Pathology, Kanazawa Medical University, Kanazawa, Japan.
Masaki Y; Department of Hematology and Immunology, Kanazawa Medical University, Kanazawa, Japan.
Tamaru JI; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło:
Pathology international [Pathol Int] 2019 Feb; Vol. 69 (2), pp. 97-103. Date of Electronic Publication: 2019 Jan 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse/*pathology
Vascular Neoplasms/*pathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Neoplastic Cells, Circulating/pathology
Czasopismo naukowe
Tytuł:
The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement.
Autorzy:
Sugimoto K; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, Dongzhimen Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. Electronic address: .
Liu J; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Kaneko K; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Miyagi National Hospital, Miyagi, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Takahashi T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Neurology, National Hospital Organization Yonezawa National Hospital, Yonezawa, Japan.
Uzawa A; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Uchida T; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Masuda H; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ohtani R; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Hiwasa T; Department of Biochemistry and Genetics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kuwabara S; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Pokaż więcej
Źródło:
Journal of neuroimmunology [J Neuroimmunol] 2019 Nov 15; Vol. 336, pp. 577021. Date of Electronic Publication: 2019 Aug 21.
Typ publikacji:
Journal Article
MeSH Terms:
Judgment*
Autoantibodies/*blood
Flow Cytometry/*standards
Myelin-Oligodendrocyte Glycoprotein/*blood
Adult ; Female ; Flow Cytometry/methods ; HEK293 Cells ; Humans ; Male ; Middle Aged ; Multiple Sclerosis/blood ; Multiple Sclerosis/diagnosis ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/diagnosis ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody.
Autorzy:
Kojima M; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan. Electronic address: .
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama 350-8550, Japan.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2019 Dec 26; Vol. 39, pp. 101907. Date of Electronic Publication: 2019 Dec 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial.
Autorzy:
Tahara M; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan. Electronic address: .
Oeda T; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Okada K; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Kiriyama T; Department of Neurology, Nara Medical University School of Medicine, Nara, Japan.
Ochi K; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Maruyama H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Fukaura H; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Mori M; Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Umemura A; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Yamamoto K; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Sawada H; Clinical Research Centre and Department of Neurology, National Hospital Organization Utano National Hospital, Kyoto, Japan.
Pokaż więcej
Źródło:
The Lancet. Neurology [Lancet Neurol] 2020 Apr; Vol. 19 (4), pp. 298-306. Date of Electronic Publication: 2020 Mar 18.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Aquaporin 4/*genetics
Immunologic Factors/*therapeutic use
Neuromyelitis Optica/*drug therapy
Rituximab/*therapeutic use
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Disability Evaluation ; Double-Blind Method ; Drug Therapy, Combination ; Evoked Potentials, Visual ; Female ; Humans ; Immunologic Factors/adverse effects ; Infusions, Intravenous ; Japan ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neuromyelitis Optica/diagnostic imaging ; Neuromyelitis Optica/genetics ; Prednisolone/therapeutic use ; Recurrence ; Rituximab/adverse effects ; Steroids/therapeutic use ; Treatment Outcome ; White Matter/diagnostic imaging ; Young Adult
Czasopismo naukowe
Tytuł:
Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
Autorzy:
Tanaka S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan. Electronic address: .
Hashimoto B; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Izaki S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Oji S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Fukaura H; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Jun; Vol. 41, pp. 102005. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
B-Lymphocyte Subsets*
Demyelinating Autoimmune Diseases, CNS*/blood
Demyelinating Autoimmune Diseases, CNS*/cerebrospinal fluid
Demyelinating Autoimmune Diseases, CNS*/immunology
Demyelinating Autoimmune Diseases, CNS*/physiopathology
Optic Neuritis*/blood
Optic Neuritis*/cerebrospinal fluid
Optic Neuritis*/immunology
Optic Neuritis*/physiopathology
T-Lymphocyte Subsets*
Aquaporin 4/*immunology
Blood-Brain Barrier/*physiopathology
Myelin-Oligodendrocyte Glycoprotein/*immunology
Adult ; Female ; Humans ; Male ; Middle Aged ; Neuromyelitis Optica/blood ; Neuromyelitis Optica/cerebrospinal fluid ; Neuromyelitis Optica/immunology ; Neuromyelitis Optica/physiopathology
Czasopismo naukowe
Tytuł:
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis.
Autorzy:
Abe T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Matsuo H; The Japanese Society for Apheresis Guidelines Preparation Committee.; Former President, The Japanese Society for Apheresis.
Abe R; The Japanese Society for Apheresis Guidelines Preparation Committee.
Abe S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Asada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ashida A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Baba A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Eguchi K; The Japanese Society for Apheresis Guidelines Working Group.
Eguchi Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Endo Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Fujimori Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furuichi K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furukawa Y; The Japanese Society for Apheresis Guidelines Working Group.
Furuya M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Furuya T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hanafusa N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hara W; The Japanese Society for Apheresis Guidelines Preparation Committee.
Harada-Shiba M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hasegawa M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hattori N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hattori M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hidaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hidaka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Hirayama C; The Japanese Society for Apheresis Guidelines Working Group.
Ikeda S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Imamura H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Inoue K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ishizuka K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ito T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Iwamoto H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Izaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kagitani M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kaneko S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kaneko N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kanekura T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kitagawa K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Kusaoi M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Lin Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Maeda T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Makino H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Makino S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Matsuda K; The Japanese Society for Apheresis Guidelines Working Group.
Matsugane T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Minematsu Y; The Japanese Society for Apheresis Guidelines Working Group.
Mineshima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Miura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Miyamoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Moriguchi T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Murata M; The Japanese Society for Apheresis Guidelines Working Group.
Naganuma M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nakae H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Narukawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nohara A; The Japanese Society for Apheresis Guidelines Preparation Committee.
Nomura K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ochi H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ohkubo A; The Japanese Society for Apheresis Guidelines Working Group.
Ohtake T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okada K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okado T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Okuyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Omokawa S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Oji S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sakai N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sakamoto Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sasaki S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sato M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Seishima M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Shiga H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Shimohata H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sugawara N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Sugimoto K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Suzuki Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Suzuki M; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tajima T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Takikawa Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tanaka S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Taniguchi K; The Japanese Society for Apheresis Guidelines Working Group.
Tsuchida S; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tsukamoto T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Tsushima K; The Japanese Society for Apheresis Guidelines Preparation Committee.
Ueda Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Wada T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamada H; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamaka T; The Japanese Society for Apheresis Guidelines Working Group.
Yamamoto K; The Japanese Society for Apheresis Guidelines Working Group.
Yokoyama Y; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yoshida N; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yoshioka T; The Japanese Society for Apheresis Guidelines Preparation Committee.
Yamaji K; The Japanese Society for Apheresis Guidelines Preparation Committee.; President, The Japanese Society for Apheresis.
Pokaż więcej
Źródło:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy [Ther Apher Dial] 2021 Dec; Vol. 25 (6), pp. 728-876.
Typ publikacji:
Journal Article; Practice Guideline
MeSH Terms:
Blood Component Removal/*methods
Blood Component Removal/*standards
Humans ; Japan ; Societies, Medical
Czasopismo naukowe
Tytuł:
Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial I-MIBG turnover can identify Lewy body disease.
Autorzy:
Kumakura Y; Department of Diagnostic Radiology and Nuclear Medicine, Saitama Medical Center (SMC), Saitama Medical University (SMU), 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. .
Shimizu Y; Department of Diagnostic Radiology and Nuclear Medicine, Saitama Medical Center (SMC), Saitama Medical University (SMU), 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
Hariu M; Department of Radiation Oncology, SMC, SMU, Kawagoe, Japan.
Ichikawa KI; Radiology Center, SMC, SMU, Kawagoe, Japan.
Yoshida N; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Suzuki M; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Oji S; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Narukawa S; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Yoshimasu H; Department of Psychiatry, SMC, SMU, Kawagoe, Japan.
Nomura K; Department of Neurology, SMC, SMU, Kawagoe, Japan.
Pokaż więcej
Źródło:
EJNMMI research [EJNMMI Res] 2021 Dec 14; Vol. 11 (1), pp. 122. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Utility of phrenic nerve conduction studies for identification of patients with neuromuscular diseases requiring invasive mechanical ventilation.
Autorzy:
Narukawa S; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Ishizuka K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Sugimoto K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło:
Muscle & nerve [Muscle Nerve] 2022 Feb; Vol. 65 (2), pp. 211-216. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Guillain-Barre Syndrome*/therapy
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating*
Humans ; Neural Conduction/physiology ; Neurologic Examination ; Respiration, Artificial
Czasopismo naukowe
Tytuł:
Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study.
Autorzy:
Hatano T; Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, Japan. .
Kano O; Department of Neurology, Faculty of Medicine, Toho University, 6-11-1 Omorinishi, Ota-ku, Tokyo, 143-8541, Japan.
Sengoku R; Department of Neurology, Jikei University Daisan Hospital, 4-11-1 Izumihoncho, Komae, Tokyo, 201-0003, Japan.
Yoritaka A; Department of Neurology, Juntendo University Koshigaya Hospital, 560 Fukuroyama, Koshigaya-shi, Saitama, 343-0032, Japan.
Suzuki K; Department of Neurology, Dokkyo Medical University Hospital, 880 Oaza Kitakobayashi, Mibu-machi, Shimotsuga-gun, Tochigi, 321-0293, Japan.
Nishikawa N; Department of Neurology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, 113-8421, Tokyo, Japan.; Department of Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira-shi, Tokyo, 187-8551, Japan.
Mukai Y; Department of Neurology, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-cho, Kodaira-shi, Tokyo, 187-8551, Japan.
Nomura K; Department of Neurology, Saitama Medical Center, Kawagoe-shi, Saitama, 350-8550, Japan.
Yoshida N; Department of Neurology, Saitama Medical Center, Kawagoe-shi, Saitama, 350-8550, Japan.
Seki M; Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Matsukawa MK; Department of Neurology, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo, 173-0015, Japan.
Terashi H; Department of Neurology, Tokyo Medical University Hospital, 6-7-1 Nishi-shinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Kimura K; Department of Neurology, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama-shi, Kanagawa, 232-0024, Japan.
Tashiro J; Sapporo Parkinson MS Neurological Clinic, Dai 27 Big Sapporo-kita Sky Building 12F, 7-6 Kita-7 jo Nishi-5 chome, Kita-ku, Sapporo-shi, Hokkaido, 060-0807, Japan.
Hirano S; Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, 260-8670, Japan.
Murakami H; Department of Neurology, The Jikei University Hospital, 3-19-18 Nishishinbashi, Minato-ku, Tokyo, 105-8471, Japan.
Joki H; Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Uchiyama T; Department of Neurology, Seirei Hamamatsu General Hospital, 2-12-12 Sumiyoshi, Naka-ku, Hamamatsu-shi, Shizuoka, 430-8558, Japan.
Shimura H; Department of Neurology, Juntendo Tokyo Koto Geriatric Medical Center, 3-3-20 Shinsuna, Koto-ku, Tokyo, 136-0075, Japan.
Ogaki K; Department of Neurology, Juntendo University Urayasu Hospital, 2-1-1 Tomioka, Urayasu-shi, Chiba, 279-0021, Japan.
Fukae J; Department of Neurology, Juntendo University Nerima Hospital, 3-1-10 Takano-dai, Nerima-ku, Tokyo, 177-8521, Japan.
Tsuboi Y; Department of Neurology, Fukuoka University School of Medicine, 7-45-1 Nanakuma, Johnan-ku, Fukuoka, 814-0180, Japan.
Takahashi K; Department of Neurology, Tokyo Metropolitan Neurological Hospital, Musashidai 2-6-1, Fuchu-shi, Tokyo, 183-0042, Japan.
Yamamoto T; Department of Neurology, Saitama Medical University Hospital, Saitama Medical University, 38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, 350-0495, Japan.
Yanagisawa N; Medical Technology Innovation Center, Juntendo University and Juntendo Clinical Research and Trial Center, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
Nagayama H; Department of Neurology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8602, Japan.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2022 Mar 03; Vol. 22 (1), pp. 71. Date of Electronic Publication: 2022 Mar 03.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Levodopa*/adverse effects
Parkinson Disease*/drug therapy
Adenosine A2 Receptor Antagonists/pharmacology ; Adenosine A2 Receptor Antagonists/therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Antiparkinson Agents/therapeutic use ; Humans ; Middle Aged ; Multicenter Studies as Topic ; Purines/pharmacology ; Purines/therapeutic use ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration.
Autorzy:
Tahara M; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan. Electronic address: .
Oeda T; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Okada K; Department of Neurology, University of Occupational and Environmental Health, Kitakyushu, Japan.
Ochi K; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Maruyama H; Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Fukaura H; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Nomura K; Department of Neurology, Saitama Medical University, Kawagoe, Japan.
Shimizu Y; Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.
Nakashima I; Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Misu T; Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Umemura A; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Yamamoto K; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Sawada H; Clinical Research Center and Department of Neurology, National Hospital Organization Utano National Hospital, 8 Ondoyama, Narutaki, Ukyo-ku, Kyoto 616-8255, Japan.
Pokaż więcej
Źródło:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2022 Apr; Vol. 60, pp. 103730. Date of Electronic Publication: 2022 Mar 07.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Neuromyelitis Optica*/chemically induced
Neuromyelitis Optica*/drug therapy
Compassionate Use Trials ; Humans ; Immunologic Factors/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Prospective Studies ; Rituximab/adverse effects ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-20 z 20

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

    Prześlij opinię

    Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

    Formularz